Myocarditis secondary prevention

	Myocarditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Adrenergic Myocarditis Giant Cell Myocarditis
Causes
Differentiating Myocarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myocarditis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Myocarditis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myocarditis secondary prevention
CDC on Myocarditis secondary prevention
Myocarditis secondary prevention in the news
Blogs on Myocarditis secondary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Myocarditis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview[edit | edit source]

Effective measures for the secondary prevention of myocarditis include, clinical evaluation, ECG, and echocardiography. CMR, cardiac CT scan, nuclear assessment in patients that echocardiography is undiagnostic. Patients should udergo cardiac function assessment at one and six months and yearly after that.

Patients should undergo cardiac function assessment at one and six months and yearly after that.

↑ Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S. B.; Fu, M.; Helio, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y. M.; Ristic, A.; Schultheiss, H.-P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P. M. (2013). "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases". European Heart Journal. 34 (33): 2636–2648. doi:10.1093/eurheartj/eht210. ISSN 0195-668X.
↑ C. L. Miklozek, E. M. Kingsley, C. S. Crumpaker, J. F. Modlin, H. D. Royal, P. C. Come, R. Mark & W. H. Abelmann (1986). "Serial cardiac function tests in myocarditis". Postgraduate medical journal. 62 (728): 577–579. doi:10.1136/pgmj.62.728.577. PMID 3774697. Unknown parameter |month= ignored (help)